Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Oligodendroglioma 1Mesothelioma, Malignant 1Gliosarcoma 1Glioma, Subependymal 1Glioma 1Glioblastoma 1Ependymoma 1Astrocytoma 1

Interventions

Temozolomide 10Radiotherapy 4Bevacizumab 4etoposide phosphate 3Surgical Procedures, Operative 32,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 3Vorinostat 2Perfusion Magnetic Resonance Imaging 2O(6)-benzylguanine 2Magnetic Resonance Spectroscopy 2Irinotecan 2Gadolinium DTPA 2Filgrastim 2Erlotinib Hydrochloride 2Dynamic Contrast Enhanced Magnetic Resonance Imaging 2Dexamethasone 2Congresses as Topic 2Carboplatin 2Calcium Dobesilate 22-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole 2vocimagene amiretrorepvec 1varlilumab 1transforming growth factor(alpha)-Pseudomonas aeruginosa exotoxin (38) 1talampanel 1sodium thiosulfate 1selinexor 1sargramostim 1regadenoson 1poly ICLC 1plerixafor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Oligodendroglioma × Etanidazole × Clear all
NCT00430079 2013-01-16

Use of EF5 to Measure the Oxygen Level in Tumor Cells of Patients Undergoing Surgery or Biopsy for Newly Diagnosed Supratentorial Malignant Glioma

National Cancer Institute (NCI)

Phase NA Terminated
48 enrolled
CNSSarcoma

Astrocytoma, Ependymoma, Glioblastoma, Glioma, Oligodendroglioma, Glioma, Subependymal, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡